Squibb-Novo's Novolin
Executive Summary
New family name for human insulin products from Squibb-Novo appears on two types of human insulin: Novolin R (short-acting regular), formerly Actrapid Human, and Novolin L (intermediate-acting Lente), formerly Monotard Human. In early 1985 the company plans to add Novolin N (NPH human insulin isophane suspension, semi-synthetic)
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.